15:10 EST Disc Medicine (IRON) down 32% to $49 after confirming rejection letter from FDA
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IRON:
- Disc Medicine confirms complete response letter from FDA for bitopertin
- Disc Medicine says issue raised by FDA ‘readily addressable’
- Disc Medicine extends decline after volatility halt
- Disc Medicine plunges after FDA posts complete response letter for bitopertin
- Disc Medicine drops 21% to $56.53 in afternoon plunge